GGrantIndex
← Leaderboards

Clyde Jason Wright

Children'S Hosp Of Philadelphia

$4,681,233
Attributed
$4,681,233
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $490.7K · FY201025
$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,681,233 · 3

By mechanism

R01$4,011,633 · 2
K08$669,600 · 1

Top collaborators

No co-investigators on record.

Most similar at Children'S Hosp Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionNeonatal Lung InjuryNeonatalLungInjuryAffectLung DevelopmentBronchopulmonary DysplasiaLung InjuryResponseIn VivoPerinatalStressCellsExposure ToMediatingLinkHepaticFetalOxidative StressAttenuatedLifeNewborn InfantImmune Signaling

Grant awards (18)

Pulmonary implications of perinatal acetaminophen exposure$418,010
R01 · FY2025 · HD · contact PI
Pulmonary implications of perinatal acetaminophen exposure$391,348
R01 · FY2024 · HD · contact PI
Pulmonary implications of perinatal acetaminophen exposure$44,616
R01 · FY2024 · HD · contact PI
Research Supplement to Promote Diversity in Health Related Research: Pulmonary implications ofperinatal acetaminophen exposure$14,522
R01 · FY2024 · HD · contact PI
Pulmonary implications of perinatal acetaminophen exposure$394,996
R01 · FY2023 · HD · contact PI
Pulmonary implications of perinatal acetaminophen exposure$77,046
R01 · FY2023 · HD · contact PI
Pulmonary implications of perinatal acetaminophen exposure$408,563
R01 · FY2022 · HD · contact PI
Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development$490,696
R01 · FY2021 · HL · contact PI
Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development$490,696
R01 · FY2020 · HL · contact PI
Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development$490,696
R01 · FY2019 · HL · contact PI
Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development$388,750
R01 · FY2018 · HL · contact PI
Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development$26,264
R01 · FY2018 · HL · contact PI
Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development$375,430
R01 · FY2017 · HL · contact PI
The unique role of IkBa in modulating NF-kB activity in the newborn lung.$133,920
K08 · FY2014 · HL · contact PI
The unique role of IkBa in modulating NF-kB activity in the newborn lung.$133,920
K08 · FY2013 · HL · contact PI
The unique role of IkBa in modulating NF-kB activity in the newborn lung.$133,920
K08 · FY2012 · HL · contact PI
The unique role of IkBa in modulating NF-kB activity in the newborn lung.$133,920
K08 · FY2011 · HL · contact PI
The unique role of IkBa in modulating NF-kB activity in the newborn lung.$133,920
K08 · FY2010 · HL · contact PI